GB202109520D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB202109520D0
GB202109520D0 GBGB2109520.3A GB202109520A GB202109520D0 GB 202109520 D0 GB202109520 D0 GB 202109520D0 GB 202109520 A GB202109520 A GB 202109520A GB 202109520 D0 GB202109520 D0 GB 202109520D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2109520.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB2109520.3A priority Critical patent/GB202109520D0/en
Publication of GB202109520D0 publication Critical patent/GB202109520D0/en
Priority to ARP220101681A priority patent/AR126255A1/en
Priority to TW111124264A priority patent/TW202317576A/en
Priority to US18/572,274 priority patent/US20240294534A1/en
Priority to PCT/EP2022/068165 priority patent/WO2023275301A1/en
Priority to EP22741247.5A priority patent/EP4363421A1/en
Priority to JP2023580802A priority patent/JP2024525044A/en
Ceased legal-status Critical Current

Links

GBGB2109520.3A 2021-07-01 2021-07-01 Therapeutic agents Ceased GB202109520D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2109520.3A GB202109520D0 (en) 2021-07-01 2021-07-01 Therapeutic agents
ARP220101681A AR126255A1 (en) 2021-07-01 2022-06-28 IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF IL-17
TW111124264A TW202317576A (en) 2021-07-01 2022-06-29 Imidazotriazine derivatives as il-17 modulators
US18/572,274 US20240294534A1 (en) 2021-07-01 2022-06-30 Imidazotriazine derivatives as il-17 modulators
PCT/EP2022/068165 WO2023275301A1 (en) 2021-07-01 2022-06-30 Imidazotriazine derivatives as il-17 modulators
EP22741247.5A EP4363421A1 (en) 2021-07-01 2022-06-30 Imidazotriazine derivatives as il-17 modulators
JP2023580802A JP2024525044A (en) 2021-07-01 2022-06-30 Imidazotriazine Derivatives as IL-17 Modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2109520.3A GB202109520D0 (en) 2021-07-01 2021-07-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB202109520D0 true GB202109520D0 (en) 2021-08-18

Family

ID=77274460

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2109520.3A Ceased GB202109520D0 (en) 2021-07-01 2021-07-01 Therapeutic agents

Country Status (1)

Country Link
GB (1) GB202109520D0 (en)

Similar Documents

Publication Publication Date Title
GB201909190D0 (en) Therapeutic agents
GB201909194D0 (en) Therapeutic agents
GB201909191D0 (en) Therapeutic agents
GB201902277D0 (en) Therapeutic agents
GB201906804D0 (en) Therapeutic agents
GB202210731D0 (en) Therapeutic agents
GB202010606D0 (en) Therapeutic agents
GB202115770D0 (en) Therapeutic agents
GB202115366D0 (en) therapeutic agents
GB202114792D0 (en) Therapeutic agents
GB202114507D0 (en) Therapeutic agents
GB202114429D0 (en) Therapeutic agents
GB202112860D0 (en) Therapeutic agents
GB202111639D0 (en) Therapeutic agents
GB202110567D0 (en) Therapeutic agents
GB202110120D0 (en) Therapeutic agents
GB202109583D0 (en) Therapeutic agents
GB202109520D0 (en) Therapeutic agents
GB202108945D0 (en) Therapeutic agents
GB202019702D0 (en) Therapeutic agents
GB202017641D0 (en) Therapeutic agents
GB202017640D0 (en) Therapeutic agents
GB202012731D0 (en) Therapeutic agents
GB202012481D0 (en) Therapeutic agents
GB202012501D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)